Drug Asset Evaluation: Increasing “Probability of Success” of a Deal
Certara’s due diligence/asset evaluation teams are comprised of drug development and commercialization experts who advise…
Danielle Pillsbury2017 年 8 月 24 日
Investigational Drug Gap Analysis
As the process of drug development has increased in cost and complexity, Certara has developed…
Danielle Pillsbury2017 年 8 月 14 日
Clinical Pharmacology—The Quarterback of Drug Development
Clinical pharmacology accounts for about 50% of a drug label. Its scope ranges from facilitating…
Certara2017 年 8 月 14 日
Mind the Gap: Best Practices in Clinical Pharmacology Gap Analysis
您是否对参加考试感到焦虑？Many people do because they want to show…
Certara2017 年 5 月 25 日
Trial Designs—Non-inferiority vs. Superiority vs. Equivalence
The primary purpose of a clinical trial is to address a scientific hypothesis. To address…
Certara2011 年 1 月 1 日
